Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

0.586
Delayed Data
As of Aug 26
 +0.0061 / +1.05%
Today’s Change
0.29
Today|||52-Week Range
1.20
-16.29%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close0.58
Today’s open0.56
Day’s range0.56 - 0.60
Volume29,269
Average volume (3 months)63,724
Market cap$83.2M
Dividend yield--
Data as of 08/26/2016

Growth & Valuation

Earnings growth (last year)+68.75%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratio3.3
Price/Sales--
Price/Book44.26

Competitors

 Today’s
change
Today’s
% change
--Innovative Pharmaceu...0.000.00%
ZFGNZafgen Inc+0.03+0.99%
MSTXMast Therapeutics In...-0.01-1.49%
NAVBNavidea Biopharmaceu...+0.01+1.55%
Data as of 08/26/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$18.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Class I Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts

Partner Offers

Search for Jobs